Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener's granulomatosis

British Journal of Rheumatology

Volumn 37, Issue 12, 1998, Pages 1303-1306

  Li, C G ^a   Reynolds, I ^a   Ponting, J M ^a   Holt, P J L ^a   Hillarby, M C ^a   Kumar, S ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Vascular endothelial growth factor; Wegener's granulomatosis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; VASCULOTROPIN;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOMA; HUMAN; NECROTIZING ARTERITIS; PATIENT MONITORING; PRIORITY JOURNAL; URINARY TRACT INFECTION; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INFLAMMATION; LYMPHOKINES; MALE; NEUTROPHILS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; WEGENER GRANULOMATOSIS;

EID: 0032413085     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hoffman GS. Wegener's granulomatosis. Curr Opin Rheumatol 1993;5:11-7.
2. Nolle B, Specks U, Ludemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989;111:28-40.
3. Exley AR, Bacon PA, Luqmani RA et al. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997;40:371-80.
4. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994;87:671-8.
5. Exley AR, Bacon PA, Luqmani RA et al. Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). Br J Rheumatol 1998;37:57-63.
6. Cohen-Tervaert JW, van der Woude FJ, Fauci AS et al. Association between active Wegener's granulomatosis and anti-cytoplasmic antibodies. Arch Intern Med 1989;149:2461-5.
7. Kerr GS, Fleisher TA, Hallahan CW et al. Limited prognostic value of changes in anti-neutrophil cytoplasmic antibody titre in patients with Wegener's granulomatosis. Arthritis Rheum 1993;36:365-71.
8. Ferrara N. The role of vascular endothelial growth factor in the regulation of blood vessel growth. In: Bicknell R, Levis CE, Ferrara N, eds. Tumour angiogenesis. Oxford: Oxford University Press, 1997:185-99.
9. Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 1996;7:259-70.
10. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev 1997;18:4-25.
11. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-9.
12. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-42.
13. Flamme I. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev Biol 1995;171: 399-414.
14. Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
15. Kallenberg CGM, Cohen-Tervaert JW, Stegeman CA. Criteria for disease activity in Wegener's granulomatosis: a requirement for longitudinal clinical studies. APMIS 1990;19(suppl.):37-9.
16. Bini P, Gabay JE, Teitel A, Melchior M, Zhou JL, Elkon KB. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognises conformation epitope(s) on proteinase-3. J Immunol 1992;149:1409-15.
17. Shima DT, Adamis AP, Ferrara N et al. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med 1995;1:182-93.
18. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
19. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 1994;28:1176-9.
20. Fujisaki K, Mitsuyama K, Toyonaga A, Matsuo K, Tanikawa K. Circulating vascular endothelial growth factor in patients with colorectal cancer. Am J Gastroenterol 1998;93:249-52.
21. Del Papa N, Guidali L, Sironi M et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996;39:758-66.